China Cuts Pharma Tariffs, Boosting Indian Exports Amid US Trade Tensions
China has eliminated its 30% import duty on Indian pharmaceutical products, allowing for duty-free exports. This strategic move comes in the wake of the US imposing a 100% tariff on pharma imports, offering Indian companies an alternative market. This change is expected to significantly boost Indian pharma exports, potentially increasing them by billions of dollars while providing Indian companies a level playing field in China’s large healthcare market. Trade analysts anticipate this will balance trade relations and strengthen India’s global healthcare supply chain.
John Q. Hosedrinker